SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study	non-small cell lung carcinoma	Recruiting	Phase 2	2026-07-07		NCT07670013

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Jiaxing University	36
Huzhou Central Hospital	31
Ningbo Medical Center Lihuili Hospital	61
Ruijin Hospital	454
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University	28
The First Affiliated Hospital of University of Science and Technology of China	31

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
2nd Affiliated Hospital, School of Medicine	Hangzhou	China	8